Catalyst Wire Dossier Catalyst Wire Dossier

LUMAKRAS

sotorasib · Amgen Inc
Drug timelines are a Plus or Pro feature.

22 regulatory and trial events tracked for LUMAKRAS, covering 2021-05-28 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial) [Phase 2]

See pricing